Quest Diagnostics
DGX
#1056
Rank
ยฃ14.51 B
Marketcap
ยฃ130.04
Share price
1.59%
Change (1 day)
20.63%
Change (1 year)
Quest Diagnostics is an American clinical laboratory company offering access to diagnostic testing services for cancer, cardiovascular disease, infectious disease, neurological disorders and employment and court ordered drug testing.

Revenue for Quest Diagnostics (DGX)

Revenue in 2024 (TTM): ยฃ7.42 Billion

According to Quest Diagnostics 's latest financial reports the company's current revenue (TTM ) is ยฃ7.56 Billion. In 2023 the company made a revenue of ยฃ7.26 Billion a decrease over the revenue in the year 2022 that were of ยฃ8.16 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Quest Diagnostics from 1997 to 2024

Annual revenue

Year Revenue Change
2024 (TTM) ยฃ7.42 B2.22%
2023 ยฃ7.26 B-11.1%
2022 ยฃ8.16 B2.22%
2021 ยฃ7.99 B15.44%
2020 ยฃ6.92 B17.51%
2019 ยฃ5.89 B-0.69%
2018 ยฃ5.93 B7.3%
2017 ยฃ5.52 B-9.21%
2016 ยฃ6.09 B20.45%
2015 ยฃ5.05 B5.88%
2014 ยฃ4.77 B10.23%
2013 ยฃ4.33 B-4.03%
2012 ยฃ4.51 B-6.57%
2011 ยฃ4.83 B1.23%
2010 ยฃ4.77 B3.61%
2009 ยฃ4.60 B-6.86%
2008 ยฃ4.94 B46.56%
2007 ยฃ3.37 B5.46%
2006 ยฃ3.20 B0.47%
2005 ยฃ3.18 B19.28%
2004 ยฃ2.67 B0.82%
2003 ยฃ2.64 B3.38%
2002 ยฃ2.56 B2.4%
2001 ยฃ2.50 B9.16%
2000 ยฃ2.29 B67.96%
1999 ยฃ1.36 B55.58%
1998 ยฃ0.87 B-5.73%
1997 ยฃ0.93 B

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
ยฃ10.08 B 33.27%๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ16.49 M-99.78%๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ0.49 B-93.41%๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ25.31 M-99.67%๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ0.17 B-97.64%๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ1.53 B-79.66%๐Ÿ‡ณ๐Ÿ‡ฑ Netherlands